VC  Vesalius Ventures

     Office Locations:

P.O. BOX 130648
Houston, TX 77219
Phone: 713-877-9276
Fax: 713-877-8669



  • Early
  • Growth
  • Seed



  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare



    Vesalius Ventures is a venture capital firm created for diversified investments, targeting large but unmet market needs, compelling technologies, exceptional management teams and superior companies. Founded in 2002 as a VC accelerator focused in medical informatics and technology (Telemedicine) and built upon the foundation of the work of the management team, Vesalius has created a firm for the evolutionary technologies in emerging markets, through the entities Vesalius Ventures, Inc. and Vesalius Capital Group, LLC. Vesalius Ventures is a venture capital vehicle solely dedicated to supporting the business development and funding of early stage technologies to advance the evolving world of medicine. The acceleration begins with identifying promising technology, developing the business opportunity, financing and bringing them to market. Vesalius Capital Group exploits opportunities in advanced technologies in the areas of clean tech, healthcare, information technology and energy. The company focuses on early-mid stage diversified investments, utilizing specialized finance strategies to bring new technologies to the market. Since its inception, Vesalius‚€™ deal flow has included over 500 companies that are leading the evolution of medicine.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Bernard A. Harris, Jr. MD, MBA Chief Executive Officer and Managing Partner
    Pamela R. Jones MBA Chief Operating Officer


    Portfolio companies include:

      Health Hero Network


      Monebo Technologies

      RMD Networks

      SWORD Health
        web link


    Recent News: